Abstract:Abnormalities in lipid and lipoprotein metabolism are commonly observed in patients with chronic renal disease. Specifically, hyperlipidemia and the glomerular deposition of atherogenic lipoproteins (e.g., Low density lipoprotein, LDL; and its oxidized variants) are implicated in key pathobiological processes involved in the development of glomerular disease, including stimulation of monocyte infiltration into the mesangial space, mesangial cell hypercellularity, and mesangial extracellular matrix deposition. This review discusses recent understanding of glomerular mitogenic responses, intracellular signaling events associated with mesangial hypercellularity in renal diseases, and the participation of cholesterol and atherogenic lipoproteins in intracellular signaling pathways involved in mesangial cell proliferation. Generally, the mitogenic intracellular signaling pathways are regulated by the activation of series of transmembrane and cytoplasmic protein tyrosine kinases that converge into the activation of Ras and down-stream mitogen-activated protein kinase (MAP kinase). Activated MAP kinase, through translocating into the nucleus and the activation of various transcription factors and protooncogenes, regulate cell proliferation. The importance of mitogenic intracellular signaling in mesangial proliferative disease has only recently been recognized and showed that the activation of MAP kinase and/or cyclin/cyclin-dependent kinases play crucial role in different phases of cell growth cycle and hypercellularity of glomerular cells in various experimental renal diseases. Using glomerular mesangial cells as an in-vitro model system, studies from our laboratory indicated that the accumulation of LDL and more potently its oxidized forms within the glomerulus, through the activation of membrane receptor tyrosine kinases (e.g., EGF receptor), activate Ras and MAP kinase signaling cascade leading to DNA synthesis and subsequent mesangial cell proliferation. These data suggest that atherogenic lipoproteins may act as one of the major endogenous modulators for mitogenic signaling response and cell proliferation within the glomerulus. It is reasonable to speculate that the correction or reduction of hyperlipidemia, glomerular lipid deposition, and the pro-oxidative milieu within the glomerulus, through the inhibition of mitogenic signaling events, may provide protective environment against mesangial hypercellularity and subsequent matrix deposition, and the progression of renal disease.

Interleukin-1β Regulates Lipid Homeostasis in Human Glomerular Mesangial Cells.

Interleukin-1β Promotes Ox-LDL Uptake by Human Glomerular Mesangial Cells Via LOX-1

Oxidized High-Density Lipoprotein Enhances Inflammatory Activity in Rat Mesangial Cells

Interferon lambda modulates proinflammatory cytokines production in PBMCs from patients with chronic kidney disease

Inflammatory Stress Exacerbated Mesangial Foam Cell Formation and Renal Injury Via Disrupting Cellular Cholesterol Homeostasis

Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions

Interleukin 1β regulates the expression of peroxisome proliferator-activated receptor γ and its coregulators in renal tubular cells

Mechanisms of Dysregulation of Low-Density Lipoprotein Receptor Expression in Vascular Smooth Muscle Cells by Inflammatory Cytokines

Interleukin-1β increases permeability and upregulates the expression of vascular endothelial-cadherin in human renal glomerular endothelial cells.

[Regulative Effects of Cytokines on the Expression of Cell Adhesion Molecules on Human Mesangial Cells].

Increased Expression Of Neutrophil Gelatinase-Associated Lipocalin Receptor By Interleukin-1 Beta In Human Mesangial Cells Via Mapk/Erk Activation

Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-β signaling in mesangial cells

Oxidized LDL Stimulates the Expression of TGF-beta and Fibronectin in Human Glomerular Epithelial Cells.

Interleukin-13 Inhibits Cytokines Synthesis by Blocking Nuclear Factor-Κb and C-Jun N-terminal Kinase in Human Mesangial Cells.

IGF-1 Alleviates Ox-Ldl-induced Inflammation Via Reducing HMGB1 Release in HAECs.

Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease

Endoplasmic reticulum stress preconditioning antagonizes low-density lipoprotein-induced inflammation in human mesangial cells through upregulation of XBP1 and suppression of the IRE1α/IKK/NF-κB pathway

Interaction of RAS Activation and Lipid Disorders Accelerates the Progression of Glomerulosclerosis.

High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells.

Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes

IL-1β Induces LDL Transcytosis by a Novel Pathway Involving LDLR and Rab27a